For: | Wu QS, Zheng DN, Ji C, Qian H, Jin J, He Q. MicroRNA-630 alleviates inflammatory reactions in rats with diabetic kidney disease by targeting toll-like receptor 4. World J Diabetes 2024; 15(3): 488-501 [PMID: 38591087 DOI: 10.4239/wjd.v15.i3.488] |
---|---|
URL: | https://www.wjgnet.com/1948-9358/full/v15/i3/488.htm |
Number | Citing Articles |
1 |
You Wang, Yuan Wang, Pei Pi, Dan Luo, Min Ning, Gang Ye. MiR-203 improved renal cell injury in diabetic nephropathy by targeting SOCS6/SOCS7 and inhibiting JAK/STAT pathway activation. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-95952-5
|
2 |
Javier Donate-Correa, Ainhoa González-Luis, Jésica Díaz-Vera, Juan Ramón Hernandez-Fernaud. MicroRNA-630: A promising avenue for alleviating inflammation in diabetic kidney disease. World Journal of Diabetes 2024; 15(7): 1398-1403 doi: 10.4239/wjd.v15.i7.1398
|
3 |
Ashraf Al Madhoun. MicroRNA-630: A potential guardian against inflammation in diabetic kidney disease. World Journal of Diabetes 2024; 15(9): 1837-1841 doi: 10.4239/wjd.v15.i9.1837
Abstract(326) |
Core Tip(319) |
Full Article(HTML)(959)
|
Full Article with Cover (PDF)-739K(60)
|
Full Article (Word)-27K(1)
|
Audio-1352K(4)
|
Peer-Review Report-194K(32)
|
Answering Reviewers-54K(44)
|
Full Article (PDF)-371K(75)
|
Full Article (XML)-74K(28)
|
Times Cited (0)
|
Total Visits (2611)
|
Open
|